[go: up one dir, main page]

NZ242733A - 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors - Google Patents

7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors

Info

Publication number
NZ242733A
NZ242733A NZ242733A NZ24273392A NZ242733A NZ 242733 A NZ242733 A NZ 242733A NZ 242733 A NZ242733 A NZ 242733A NZ 24273392 A NZ24273392 A NZ 24273392A NZ 242733 A NZ242733 A NZ 242733A
Authority
NZ
New Zealand
Prior art keywords
amino
naphthyridine
medicaments
quinoline
dihydro
Prior art date
Application number
NZ242733A
Inventor
Jordi Corbera-Arjona
Jordi Frigola-Constansa
Juan Pares-Corominas
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NZ242733A publication Critical patent/NZ242733A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
NZ242733A 1991-05-16 1992-05-14 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors NZ242733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105937A FR2676445B1 (en) 1991-05-16 1991-05-16 SUBSTITUTED PYRIDONE AMINO ACID AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.

Publications (1)

Publication Number Publication Date
NZ242733A true NZ242733A (en) 1994-06-27

Family

ID=9412841

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ242733A NZ242733A (en) 1991-05-16 1992-05-14 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors

Country Status (20)

Country Link
EP (1) EP0514268A1 (en)
JP (1) JPH05132479A (en)
KR (1) KR920021528A (en)
CN (1) CN1066656A (en)
AU (1) AU660311B2 (en)
CA (1) CA2068853A1 (en)
CZ (1) CZ147992A3 (en)
ES (1) ES2039192B1 (en)
FI (1) FI922225A (en)
FR (1) FR2676445B1 (en)
HU (1) HUT61304A (en)
IL (1) IL101886A0 (en)
IS (1) IS3862A (en)
MA (1) MA22526A1 (en)
MX (1) MX9202273A (en)
NO (1) NO921908L (en)
NZ (1) NZ242733A (en)
OA (1) OA09794A (en)
PL (1) PL294561A1 (en)
ZA (1) ZA923538B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289999T1 (en) 1996-07-12 2005-03-15 Daiichi Seiyaku Co CIS-SUBSTITUTED AMINOCYCLOPROPANE DERIVATIVES
KR100613690B1 (en) * 2004-07-30 2006-08-21 한국화학연구원 4-quinolinone derivatives and agricultural and horticultural germicide compositions comprising the same
KR100613688B1 (en) * 2004-08-30 2006-08-21 한국화학연구원 2-amino-4-quinolinone derivatives and agrohorticultural fungicide compositions comprising the same
CA2587985C (en) 2004-11-24 2016-05-10 Neopro Labs, Llc Peptides for use in treatment in fever or pain
WO2007112453A2 (en) 2006-03-28 2007-10-04 Neopro Labs, Llc Methods amd compositions for treating conditions
US8217141B2 (en) 2007-05-17 2012-07-10 Neopro Labs, Llc Crystalline and amorphous forms of peptide
CN101898990B (en) * 2009-06-01 2012-12-19 中国科学院化学研究所 Method for catalyzing and synthesizing chirality azetidine amide and carboxylic acid compound by microorganism system
WO2022198231A1 (en) 2021-03-18 2022-09-22 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3306771A1 (en) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen CHINOLONIC CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
DE3580183D1 (en) * 1984-04-26 1990-11-29 Abbott Lab ANTIBACTERIAL CHINOBENZOXAZINE COMPOUNDS.
US4617308A (en) * 1985-01-25 1986-10-14 Warner-Lambert Company 7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
FR2634483B2 (en) * 1987-12-29 1994-03-04 Esteve Labor Dr DERIVATIVES OF ACIDS 7- (1-AZETIDINYL) -1,4-DIHYDRO-4-OXOQUINOLEINE-3-CARBOXYLIQUES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
IL91648A (en) * 1988-09-22 1997-03-18 Abbott Lab Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
AU5123690A (en) * 1989-03-13 1990-09-13 Bristol-Myers Squibb Company 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents
NO177302C (en) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogous Process for Preparing Therapeutically Active Substituted Azetidinyl Quinolone (Naphthyridone) Carboxylic Acid Derivatives
FR2645862B1 (en) * 1989-04-18 1991-07-12 Esteve Labor Dr SUBSTITUTED ISOTHIAZOLO-PYRYDONE AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2649100B1 (en) * 1989-06-29 1994-03-04 Laboratorios Dr Esteve Sa NOVEL AZETIDINES, THEIR PREPARATION AND THEIR APPLICATION AS INTERMEDIATES FOR THE PREPARATION OF COMPOUNDS WITH ANTIMICROBIAL ACTIVITY

Also Published As

Publication number Publication date
NO921908L (en) 1992-11-17
MX9202273A (en) 1993-05-01
FR2676445B1 (en) 1995-02-03
HU9201621D0 (en) 1992-08-28
ES2039192A1 (en) 1993-09-01
NO921908D0 (en) 1992-05-14
HUT61304A (en) 1992-12-28
PL294561A1 (en) 1993-05-04
EP0514268A1 (en) 1992-11-19
CZ147992A3 (en) 1993-09-15
ZA923538B (en) 1993-01-27
AU660311B2 (en) 1995-06-22
MA22526A1 (en) 1992-12-31
KR920021528A (en) 1992-12-18
CA2068853A1 (en) 1992-11-17
FI922225A0 (en) 1992-05-15
AU1624992A (en) 1992-11-19
ES2039192B1 (en) 1994-04-01
FI922225A (en) 1992-11-17
IL101886A0 (en) 1992-12-30
JPH05132479A (en) 1993-05-28
FR2676445A1 (en) 1992-11-20
OA09794A (en) 1994-04-15
IS3862A (en) 1992-11-17
CN1066656A (en) 1992-12-02

Similar Documents

Publication Publication Date Title
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
IL112193A (en) 6-(2-arylpyrazolo¬1,5-A¾pyridine-3-yl)-2-substituted pyridazin-3(2H)-one derivatives processes for the preparation thereof and pharmaceutical compositions containing them
EP0370704A3 (en) Aralkylamine derivatives, preparation thereof and bactericides containing the same
IL87731A (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HU208256B (en) Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
PL299929A1 (en) Quinoxaline derivatives, method of obtaining sames and their use in drugs
NZ242733A (en) 7-(3-amino acid amino-substituted azetidin-1-yl)-1,4-dihydro-4-oxo-quinoline-(and-1,8-naphthyridine)-3- carboxylic acid derivatives, medicaments, and precursors
AU644540B2 (en) Imidazopyridine derivatives and process for preparation thereof
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
IL103151A0 (en) Beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ229346A (en) Oxadiazolyl-substituted imidazo(1,5-a)quinoxaline derivatives and pharmaceutical compositions
AU2141695A (en) Imidazo{1,2-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
HUT70955A (en) 3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
PH23930A (en) Pyrido(3.2.1-ij)-1,3,4 benzocadiazine derivatives and method of use thereof
EP0556671A3 (en) Triazolopyridine derivatives, process for their preparation and their use as microbicides
AU2457688A (en) New fluoromethoxyphenyl dihydropyridines, processes for the preparation and their use in medicaments
IL102027A0 (en) Cephem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
NZ238428A (en) Cephalosporin derivatives and medicaments
IL84331A0 (en) Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same
HUT57776A (en) Process for producing pyrido(3,4-b)(1,4)benzoxazepine derivatives and pharmaceutical compositions comprising same
ZA872443B (en) Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
EP0549263A3 (en) A process for the preparation of n-alkyl-3,4-dialkyloxyanilines and derivatives thereof
NZ226494A (en) 2,3-dioxabicyclo(3.3.1)nonan-7-one derivatives, medicaments and precursors
GB2270313B (en) 1,3,4-Benzotriazepin-5 (4H)-one derivatives and process for the preparation thereof